Archives
-
PPT: ERα Signaling Workflows in LUAD
2026-09-25
PPT provides a selective way to test whether ERα activation changes candidate gene or cell-state readouts in estrogen-receptor-positive models. This practical guide connects its use to a female lung adenocarcinoma study while distinguishing a useful experimental hypothesis from evidence the study did not establish.
-
EZ Cap™ Cy5 EGFP mRNA: Beyond Uptake
2026-09-24
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) pairs a Cy5-labeled mRNA delivery signal with EGFP expression to distinguish cellular association from productive translation. This article connects that dual-readout strategy to new structural insights into RNA–polymer assemblies and explains how to interpret reporter results without overcalling delivery.
-
(Z)-4-Hydroxytamoxifen in Relapse Research
2026-09-24
Discover how (Z)-4-Hydroxytamoxifen can help dissect estrogen receptor signaling while keeping endocrine pharmacology distinct from genetic tumor-relapse models. A 2025 proliferation-tracing study offers practical lessons for experimental timing, cell-state analysis, and interpreting recurrence.
-
Annexin V-Cy5 Apoptosis Kit in Microglia
2026-09-23
Learn how the Annexin V-Cy5 Apoptosis Kit can help distinguish phosphatidylserine exposure from lysosomal dysfunction in microglia. This article translates a reversible zebrafish microglial stress model into practical choices for apoptosis assay design and interpretation.
-
PINK1/Park2 Mitophagy in NAFLD
2026-09-23
The reference study links Park2-dependent mitophagy with reduced lipid accumulation, inflammatory signaling, and mitochondrial injury in an oleic acid-based cellular model of non-alcoholic fatty liver disease. Its combination of Park2 gain- and loss-of-function experiments with mitochondrial imaging and LC3 localization provides mechanistic evidence, while the lack of in vivo validation leaves important questions about clinical transferability.
-
EZ Cap EGFP mRNA 5-moUTP for Assay Control
2026-09-22
Discover how EZ Cap EGFP mRNA 5-moUTP can function as more than an EGFP reporter: it provides a practical control for mRNA delivery, translation efficiency, stability, and immune-compatible assay design.
-
Estradiol–Autophagy Axis in Perimenopausal Aging
2026-09-22
This study integrates NHANES analyses, network pharmacology, and perimenopausal mouse experiments to examine how declining estradiol relates to cardiometabolic and renal disease risk. Its central contribution is evidence that receptor-dependent autophagy, including mTOR-associated signaling, helps preserve the heart, aorta, and kidneys during estrogen loss.
-
From EGFP Signal to Translational Confidence
2026-09-21
A mechanistic and strategic guide to using EZ Cap™ EGFP mRNA (5-moUTP) as a benchmark for mRNA delivery, translation, innate immune activation, and translational decision-making.
-
Estradiol, ER Signaling, and T-Cell Recovery After Shock
2026-09-21
The reference study shows that estradiol restores splenic CD4+ T-cell proliferation and cytokine production after hemorrhagic shock by engaging ERα and GPR30-associated signaling while suppressing endoplasmic reticulum stress. Its pharmacologic design separates receptor subtype effects from ER-stress effects, offering a useful framework for studying hormone–immune interactions while emphasizing the limits of translation from an acute rat model.
-
Thapsigargin: From Ca2+ Flux to Necroptosis
2026-09-20
Thapsigargin is a potent SERCA pump inhibitor for resolving how ER calcium depletion reshapes cell-death signaling. This article develops an assay framework linking calcium kinetics, ER stress, apoptosis, and necroptosis without treating them as interchangeable outcomes.
-
4μ8C and ER Stress: Branch-Specific Assays
2026-09-19
Explore how 4μ8C can resolve IRE1α RNase signaling from PERK-driven ER stress, with practical guidance for hypoxia response modulation, cancer research, and emerging inflammation models.
-
EZ Cap™ ER-EGFP Probe mRNA Guide
2026-09-18
EZ Cap™ ER-EGFP Probe mRNA (m1Ψ) is an ER-directed fluorescent mRNA probe for visualizing reporter signal in cell-based experiments. The cited osteogenesis study links PFKM suppression to MERC expansion, calcium-dependent DRP1 remodeling, and mitochondrial quality control, but it does not evaluate this product directly.
-
4-Phenylbutyric Acid for ER Stress Studies
2026-09-18
4-Phenylbutyric acid provides a practical rescue-control strategy for testing whether proteostasis disruption drives autophagic or apoptotic phenotypes. This workflow combines chemical-chaperone treatment with viability, ER-stress, and autophagy readouts to distinguish correlation from mechanism.
-
Capillarisenol C Drives ER Stress–Dependent Autophagy
2026-09-17
The reference study identifies capillarisenol C, a bisphenol isolated from Artemisia capillaris, as an inducer of endoplasmic reticulum stress-associated cytotoxic autophagy in HepG2 and Huh7 liver cancer cells. Its pharmacological rescue and genetic experiments connect PERK–eIF2α and IRE1 activation with autophagy-dependent cell death, providing a framework for mechanistic ER stress and apoptosis research.
-
ATRX-Deficient Glioma and RTK Inhibitor Sensitivity
2026-09-17
The reference study identifies ATRX deficiency as a potential determinant of sensitivity to multi-targeted receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma cells. It further reports pronounced toxicity when these inhibitors are combined with temozolomide, providing a rationale for incorporating ATRX status into glioma drug studies and clinical-trial analyses.